Allied Corp., an international medical cannabis company, announced the resignation of David Weinkauf as a director and the resignation of Anthony Zelen as a director of the Company both due to personal reasons and to pursue other professional opportunities. Calum Hughes, CEO, has expressed appreciation for both of their contributions to the development of the Company on behalf of the Board of Directors and management team.
“On behalf of the Board of Directors, I would like to thank David and Anthony for their many contributions to Allied as directors over the past year. Under David and Anthony’s stewardship, Allied has successfully positioned itself as a leader within the sector and within the North American public markets. We wish them all the best in their future endeavors,” commented Calum Hughes, CEO.
For more information on Allied Corp. visit www.allied.health
Allied Corp. is an international medical cannabis production company with a mission to address today’s medical issues by researching, creating and producing targeted cannabinoid health solutions. Allied Corp. uses an evidence-informed scientific approach to make this mission possible, through cutting-edge pharmaceutical research and development, innovative plant-based production and unique development of therapeutic products.